Cencora, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cencora, Inc. on May 22, 2024. The filing primarily addresses a material definitive agreement regarding a share repurchase and the subsequent issuance of a press release updating fiscal year guidance.
Key Financial Metrics and Transaction Details
- Share Repurchase: The Company agreed to repurchase 1,859,390 shares of common stock from Walgreens Boots Alliance Holdings LLC.
- Transaction Price: The repurchase price was $215.1244 per share.
- Total Cost: The aggregate price paid was approximately $400 million.
- Transaction Date: The repurchase was consummated on May 24, 2024.
- Shareholder Impact: Post-repurchase, the Selling Stockholder owns approximately 12% of the Company's outstanding common stock (24,418,171 shares).
- Outstanding Shares: Based on May 22, 2024 data, total outstanding shares were 198,787,917 prior to the repurchase.
Material Changes and Guidance
Concurrent with the share repurchase announcement, Cencora issued a press release raising its fiscal year 2024 adjusted diluted earnings per share (EPS) guidance. The filing does not provide the specific numerical values for the updated guidance, only that an increase was announced.
Risks, Contingencies, and Unusual Items
The filing notes that the information regarding the guidance update is furnished under Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting its incorporation by reference into other documents. No other material risks or contingencies are detailed in this specific report.
Key Facts for Investor Verification
- Verify the specific numerical targets for the raised fiscal year 2024 adjusted diluted EPS guidance in the press release (Exhibit 99.1).
- Confirm the impact of the $400 million cash outflow on the Company's current liquidity position and cash flow statement.
- Review the full Share Repurchase Agreement (Exhibit 10.1) for any additional covenants or conditions.
- Monitor the Selling Stockholder's remaining 12% stake for potential future divestiture or voting implications.